Neurolepticlike actions of l-methadone: effect on mescaline-induced altered behavior and on tissue levels of mescaline in mice.
Mice were injected ip with either saline, l-methadone (2.5, 5, 20 mg/kg), perphenazine (1, 10, 15 mg/kg), or chlorprothixene (1.25, 2.5, 15 mg/kg) 30 min prior to mescaline-14C (25 mg/kg). Mescaline-induced behavioral changes such as agitation, excitement, slight increase in ventilation, and fright to sound stimuli were prevented by all doses of three drugs, and head-shaking, scratching, and locomotor-increasing effects by 5 and 20 mg/kg methadone and by all doses of both neuroleptics. Catalepticlike state and moderate to marked hypothermia induced by all doses of chlorprothixene, 10 and 15 mg/kg perphenazine, and 20 mg/kg methadone were not reversed by mescaline. Chlorprothixene (all doses), perphenazine (10, 15 mg/kg), and methadone (5, 20 mg/kg) caused marked retention of mescaline and its deaminated metabolite, 3, 4, 5-trimethoxyphenyl acetic acid in both brain and plasma. The fact that relatively higher doses of methadone than neuroleptics are needed to ensure effective antagonism to mescaline action tends to indicate a less specific interaction of the opiate with the neuroleptic/dopamine receptor proposed for central mescaline effects.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001711:Biotransformation; D001831:Body Temperature / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D002749:Chlorprothixene / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006120:Grooming / Q000187:drug effects; D008297:Male; D008635:Mescaline / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology*; D008657:Metabolic Clearance Rate / Q000187:drug effects; D008691:Methadone / Q000494:pharmacology*; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010546:Perphenazine / Q000494:pharmacology
D002749:Chlorprothixene; D010546:Perphenazine; D008635:Mescaline; D008691:Methadone